Kerry Holford

Stock Analyst at Berenberg

(1.79)

# 3,237

Out of 5,182 analysts

10

Total ratings

42.86%

Success rate

8.02%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Kerry Holford

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVO Novo Nordisk	Upgrades: Buy	n/a	$41.17	-	1	Sep 17, 2025
	LLY Eli Lilly and Company	Downgrades: Hold	$970 → $830	$874.00	-5.03%	9	Sep 17, 2025

Novo Nordisk

Sep 17, 2025

Upgrades: Buy

Price Target: n/a

Current: $41.17

Upside: -

Eli Lilly and Company

Sep 17, 2025

Downgrades: Hold

Price Target: $970 → $830

Current: $874.00

Upside: -5.03%